Management Sciences for Health Tapped to Quantify the Economic Toll of Malaria and Spur Smarter Investment Across Africa

Arlington, VA–June 16, 2025–Management Sciences for Health (MSH) today announced a new partnership with Malaria No More UK (MNMUK) and the African Leaders Malaria Alliance (ALMA) to demonstrate how malaria undermines economic growth across Africa—and how strategic investment in controlling the disease can drive national development.

This research and advocacy effort will quantify malaria’s cross-sectoral impacts, including effects on workforce productivity, tourism, education, and GDP. MSH will model how targeted investments in malaria response can yield economic returns and contribute to stronger, more resilient systems.

“Malaria is not just a health issue—it’s a critical development issue,” said Justice Nonvignon, Technical Director for Health Economics and Financing at MSH. “By demonstrating how malaria affects productivity, learning, and growth, we can help governments and partners make smarter investment decisions.”

Deliverables will include reports on multi-country modeling, country deep-dives and targeted briefs to support MNMUK and ALMA advocacy to ministries of health and finance, donors and private sector actors.

This work builds on MSH’s global leadership in malaria programming and health economics—including multi-country analyses on the cost-effectiveness of seasonal malaria chemoprevention and investment cases that have helped unlock funding for community health services.

The project will run through August 2025, with outputs expected to shape the global malaria financing narrative well into 2026.

Learn more about our work on health care financing: https://msh.org/health-care-financing/